The opinion in support of the decision being entered today was not written for
publication and is not binding precedent of the Board.
Paper No. 24
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte PAUL AVERBACK
__________
Appeal No. 1999-0494
Application 08/482,768
__________
ON BRIEF
__________
Before WILLIAM F. SMITH, ADAMS, and GRIMES Administrative Patent Judges.
WILLIAM F. SMITH, Administrative Patent Judge.
DECISION ON APPEAL
This is an appeal under 35 U.S.C. § 134 from the final rejection of claims 13
through 15 and 17 through 21, all the claims pending in the application.
Claims 13, 14, and 15 are representative of the subject matter on appeal and
read as follows:
13. A composition comprising (a) a therapeutically effective amount of a compound
that inhibits formation of amyloid fibrils when administered, at an in-tissue concentration
of about 10-5 M or less, to a test animal that has received an intracerebral injection of
DMS and (b) a pharmaceutically acceptable carrier, wherein said composition is
capable of crossing the blood-brain barrier.
Page: 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007